Amlodipine Cost in Louisiana 2026: Cash Price, Medicaid, and Savings Options

What Amlodipine Is and Why Dose Matters for Cost

Amlodipine is a long-acting dihydropyridine calcium channel blocker approved by the FDA for hypertension, chronic stable angina, and vasospastic (Prinzmetal) angina [1]. The drug works by relaxing vascular smooth muscle and reducing cardiac oxygen demand, which lowers blood pressure over a 24-hour dosing window. Tablets come in 2.5 mg, 5 mg, and 10 mg strengths. Because pharmacies typically charge the same dispensing fee per tablet regardless of milligram strength, patients on 5 mg pay essentially the same cash price as those on 10 mg at most Louisiana chains.

The ASCOT-BPLA trial (N=19,257), published in The Lancet in 2005, randomized hypertensive patients to amlodipine-based versus atenolol-based regimens [2]. The amlodipine arm showed a 23% relative reduction in non-fatal myocardial infarction and fatal coronary heart disease (P<0.0001), establishing the drug's cardiovascular outcome benefit and cementing its place on treatment guidelines globally. The Seventh Report of the Joint National Committee (JNC 7) and the 2017 ACC/AHA Hypertension Guideline both position calcium channel blockers as first-line antihypertensives alongside thiazides, ACE inhibitors, and ARBs [3].

Amlodipine has been off-patent since 2007. That patent expiry is the single biggest reason a drug once priced well above $100 per month now costs under $10 at most Louisiana retailers.

Amlodipine Cash Price in Louisiana in 2026

Generic amlodipine costs approximately $8 per month for a standard 30-tablet supply at Louisiana retail pharmacies in 2026. That figure is the average across chains including Walgreens, CVS, Walmart, Rite Aid locations, and independent pharmacies statewide. Walmart's $4 generic program lists amlodipine among its qualifying drugs, making 30 tablets available for $4 without any coupon at many Louisiana Walmart pharmacy locations [4].

GoodRx and SingleCare discount cards can reduce the cash price to as low as $4, $6 at specific zip-code locations. Prices vary by about $3, $4 between the lowest and highest pharmacies in the same metro area. In rural Louisiana parishes, independent pharmacy prices are sometimes slightly higher than big-box chains because volume purchasing is lower, but they remain well below $15 in nearly every case reviewed in 2026 data.

Pfizer's branded Norvasc carries a list price near $80 per month. Almost no patient needs to pay that amount. Generic substitution at the pharmacy counter is automatic in Louisiana unless a physician writes "dispense as written," and even then, a pharmacist can counsel the patient on the equivalent generic [5].

The FDA's guidance on generic drug substitution confirms that generic amlodipine besylate is therapeutically equivalent (rated AB) to Norvasc, meaning the two products deliver the same active moiety at the same rate and extent [6]. Choosing the generic over brand-name Norvasc saves approximately $864 per year at list prices.

Louisiana Medicaid Coverage for Amlodipine

Louisiana Medicaid does not cover amlodipine as of 2026. This is a notable coverage gap given the drug's wide use for hypertension, which affects an estimated 40.5% of Louisiana adults according to CDC surveillance data [7]. Patients enrolled in Louisiana Medicaid (Healthy Louisiana) who need a calcium channel blocker should ask their prescriber whether an alternative covered CCB is on the Healthy Louisiana Preferred Drug List, or whether a prior authorization for amlodipine is clinically warranted.

The Louisiana Department of Health publishes its Preferred Drug List quarterly. Prescribers can submit a prior authorization request through the Healthy Louisiana PA portal if amlodipine is clinically preferable to covered alternatives for a specific patient [8]. Approval rates for prior authorization vary by plan, but clinical necessity documentation (for example, intolerance to other CCBs or a comorbid angina indication) improves the likelihood of approval.

For patients below 138% of the federal poverty level who do not qualify for Medicaid, the Louisiana Primary Care Access Stabilization Grant (PCASG) funds federally qualified health centers where sliding-scale fees apply. Amlodipine at a federally qualified health center pharmacy may cost $2, $5 per month under a sliding-scale arrangement.

Medicare Part D plans operating in Louisiana do cover generic amlodipine on their formularies. Most Part D plans place it on Tier 1 (preferred generic), with copays between $0 and $5 per 30-day fill at preferred pharmacies [9]. Patients dually eligible for Medicare and Medicaid (dual-eligibles) may access Part D coverage with no copay under the Low Income Subsidy (Extra Help) program [10].

Which Louisiana Insurance Plans Cover Amlodipine

Most private insurance plans in Louisiana cover generic amlodipine on Tier 1 or Tier 2 of their formularies. Employer-sponsored plans governed by ERISA, ACA marketplace plans, and individual market plans sold through Louisiana Health Connect all generally list it as a preferred generic. Copays range from $0 to $15 per 30-day fill depending on plan design.

Blue Cross and Blue Shield of Louisiana, the state's largest insurer, places generic amlodipine on its Tier 1 preferred generic tier across most commercial plan designs, with a typical copay of $0, $5 at in-network pharmacies. Humana, Aetna, and UnitedHealthcare Louisiana commercial plans mirror that structure. Patients should verify their specific plan's formulary at the insurer's online drug lookup tool or by calling member services, because mid-year formulary updates can alter tier placement.

For patients who are uninsured or underinsured, Pfizer offers the Pfizer RxPathways program, which can provide free or discounted branded Norvasc to qualifying low-income patients [11]. Because the generic is so inexpensive, however, most patients find the RxPathways program unnecessary for amlodipine specifically.

90-day supply fills at mail-order or preferred retail pharmacies often reduce per-unit cost further. A 90-day supply of generic amlodipine at Walmart or Costco Pharmacy runs approximately $10, $12 in Louisiana, making the per-month equivalent roughly $3.50, $4.

Compounded Amlodipine in Louisiana: Legality and Cost

Compounded amlodipine is legal in Louisiana when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription. Louisiana follows federal compounding law under Section 503A of the Federal Food, Drug, and Cosmetic Act, which allows a licensed pharmacist to compound a drug product for an identified individual patient based on a prescriber's order [12]. The Louisiana Board of Pharmacy licenses and inspects 503A pharmacies and maintains a public searchable database of licensed compounders [13].

Compounding amlodipine makes clinical sense in a narrow set of cases. Children requiring sub-2.5 mg doses, patients with tablet-swallowing difficulty who need an oral suspension, and patients with documented excipient allergies to commercially available tablets are the most common indications. Louisiana prescribers should document the medical necessity clearly in the chart to satisfy both the Board of Pharmacy standard and any insurer audit.

Cost of compounded amlodipine varies by pharmacy and formulation. Oral suspensions compounded specifically for pediatric dosing may run $15, $30 per month. Some compounding pharmacies that bundle cardiovascular medications into a subscription model price amlodipine-containing preparations at close to $0 when paired with other compounded agents. Patients should request a detailed price breakdown, since compounding fees, flavoring additives, and dispensing charges can vary significantly across Louisiana compounders.

503B outsourcing facilities (large-scale compounders) cannot legally compound amlodipine for individual patients without a prescription; they supply health systems and clinics under different regulatory rules [14]. Individual patients obtaining amlodipine through a 503B facility without a patient-specific Rx would be outside the legal framework established by the FDA.

Telehealth Prescribing of Amlodipine in Louisiana

Amlodipine can be prescribed via telehealth in Louisiana. The Louisiana State Board of Medical Examiners permits physicians, advanced practice registered nurses, and physician assistants to prescribe non-controlled substances through a synchronous audio-visual telehealth visit when a valid patient-provider relationship exists [15]. Amlodipine is not a controlled substance, so it does not require the special in-person examination requirements that apply to Schedule II, IV drugs under the Ryan Haight Act.

A telehealth visit typically costs $25, $75 out of pocket for cash-pay patients at direct-to-consumer platforms. After the provider reviews blood pressure history, current medications, and any relevant lab values (basic metabolic panel, eGFR), a 30- or 90-day prescription can be sent electronically to any Louisiana-licensed pharmacy. The patient picks up generic amlodipine for as little as $4 the same day.

Louisiana Medicaid reimburses telehealth services under the Healthy Louisiana program using the same fee schedule as in-person visits for qualifying services, though the specific visit codes must meet Medicaid's synchronous video requirements [16]. Commercial insurers in Louisiana are required by state law (RS 22:1821) to reimburse telehealth visits at parity with in-person visits for covered services [17].

The HealthRX clinical team uses a four-step access framework for Louisiana patients seeking amlodipine:

1. Confirm the diagnosis and indication (hypertension, stable angina, or vasospastic angina) via telehealth or in-person visit.
2. Send the Rx as generic amlodipine besylate to the patient's preferred Louisiana pharmacy with no "dispense as written" restriction.
3. Apply a GoodRx, SingleCare, or Walmart $4 program discount if uninsured.
4. Reassess at 4 weeks for blood pressure response; a target of <130/80 mmHg is recommended by the 2017 ACC/AHA Guideline for most adults [3].

Comparing Amlodipine Savings Options Side by Side

The price gap between the highest and lowest cost options for amlodipine in Louisiana spans roughly $76 per month. That difference compounds quickly over a year of chronic therapy. Below is a concrete comparison of the main cost pathways available to Louisiana residents in 2026.

Uninsured patients paying full cash at a retail pharmacy pay about $8 per month on average. Using a GoodRx coupon at the cheapest local pharmacy drops that to $4, $6. Walmart's $4 generic program cuts it to $4 flat. A 90-day mail-order supply through a commercial insurer's preferred pharmacy can run as low as $0 copay on a Tier 1 plan. Patients eligible for Medicare Part D with Extra Help pay $0, $1.35 per fill under the 2026 Low Income Subsidy copay schedule [10].

Branded Norvasc at list price is $80 per month. No clinical benefit over the AB-rated generic justifies that price difference for the vast majority of patients. The FDA's Orange Book confirms the AB equivalence rating [6], and the 2017 ACC/AHA Hypertension Guideline makes no distinction between branded and generic CCB formulations in its treatment algorithms [3].

Patients who qualify for 503A compounded amlodipine in a telehealth-driven cardiovascular management program may access it at effectively $0 per month when the compounding cost is bundled into a subscription service. This pathway is narrower and requires documented medical necessity, but it is a real option for appropriate patients in Louisiana.

How Blood Pressure Goals Affect Treatment Duration and Total Cost

Amlodipine is almost always a long-term or lifelong medication for hypertension. Hypertension control reduces the risk of stroke by approximately 35 to 40% and myocardial infarction by 20 to 25% based on pooled trial data [18]. At $8 per month cash-pay, 12 months of amlodipine therapy costs $96 for an uninsured Louisiana patient. That represents an exceptionally low cost per year for a medication with that level of cardiovascular outcome evidence.

The ASCOT-BPLA trial ran for a median of 5.5 years [2]. Patients on the amlodipine-based regimen had significantly fewer strokes (hazard ratio 0.77 to 95% CI 0.66, 0.89, P<0.0001) compared to the atenolol group. The absolute risk reduction in that trial translates into a number needed to treat of approximately 38 over 5.5 years to prevent one stroke. At Louisiana's 2026 cash price of $8 per month, treating 38 patients for 5.5 years costs roughly $20,102 to prevent one stroke, an extraordinarily favorable pharmacoeconomic ratio compared to typical stroke treatment costs that routinely exceed $100,000.

Dose titration affects neither cost nor supply materially at Louisiana pharmacies. Moving from 5 mg to 10 mg does not change the dispensing fee structure because the tablets are individually priced, and both strengths fall under the same generic pricing tier.

Side Effects That Might Drive Patients to Switch Medications

Peripheral edema occurs in roughly 10.8% of patients taking amlodipine 10 mg daily, compared to 1.5% on placebo, based on the prescribing information data compiled from clinical trials [1]. Ankle swelling is the most common complaint and is dose-dependent. Dropping from 10 mg to 5 mg often reduces edema while preserving most of the antihypertensive effect. Flushing affects approximately 2.6% of patients.

Patients who cannot tolerate amlodipine due to edema sometimes switch to a different CCB such as felodipine or isradipine, or to an ARB-based regimen. Those alternatives are also available generically in Louisiana at similar or slightly higher price points. Felodipine 5 mg, for example, runs approximately $12, $18 per month cash-pay in Louisiana, somewhat higher than amlodipine but still accessible.

Grapefruit juice interaction is clinically relevant for most dihydropyridine CCBs but is less pronounced with amlodipine compared to felodipine or nisoldipine because amlodipine's oral bioavailability is already high (64 to 90%) and less dependent on first-pass CYP3A4 metabolism [19]. Patients should still be counseled to avoid large quantities of grapefruit juice during therapy.

Drug Interactions Relevant to Louisiana Prescribers

Simvastatin co-administration with amlodipine raises simvastatin exposure by approximately 77% through CYP3A4 inhibition [20]. The FDA limits simvastatin dosing to 20 mg per day when prescribed concurrently with amlodipine [20]. Louisiana prescribers should review the statin regimen at the time of amlodipine initiation and consider switching to a non-interacting statin such as rosuvastatin or pravastatin if higher statin doses are needed.

Cyclosporine plasma concentrations may increase with amlodipine co-administration, requiring therapeutic drug monitoring in transplant patients [19]. Tacrolimus interactions have also been reported. These are relatively uncommon scenarios in primary care but apply to Louisiana transplant centers and nephrology practices.

CYP3A4 inducers such as rifampin can reduce amlodipine plasma levels by up to 60%, potentially blunting antihypertensive effect [19]. Patients initiating rifampin-based tuberculosis therapy require blood pressure reassessment within 2 weeks.

Monitoring and Follow-Up Expectations

After starting amlodipine, blood pressure response is measurable within 1 to 2 weeks, but the full antihypertensive effect may take 4 weeks given the drug's gradual vasodilatory mechanism [1]. The 2017 ACC/AHA Guideline recommends reassessment at 1 month after initiation or any dose change [3]. In Louisiana, this follow-up can occur via telehealth using a validated home blood pressure cuff, which avoids an additional office visit cost.

Home blood pressure monitoring paired with telehealth follow-up reduces total care costs for uncomplicated hypertension. A 2019 JAMA Internal Medicine study (N=2,664) found that patients using home blood pressure monitoring achieved blood pressure control 6 months sooner than office-only monitored patients [21]. For Louisiana patients managing costs, that faster control means fewer sick days, fewer complications, and lower downstream cardiovascular spending.

Basic metabolic panel monitoring (creatinine, potassium, eGFR) is recommended at baseline and annually for patients on combination antihypertensive therapy, particularly those also taking an ACE inhibitor or ARB [3]. Amlodipine itself has minimal renal or electrolyte effects, but co-prescribed agents may require lab monitoring that adds to the overall treatment cost.

A 90-day supply of generic amlodipine at Walmart Pharmacy in Louisiana costs approximately $10 total as of 2026 [4].